These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31967783)

  • 1. The Q
    Wall RJ; Carvalho S; Milne R; Bueren-Calabuig JA; Moniz S; Cantizani-Perez J; MacLean L; Kessler A; Cotillo I; Sastry L; Manthri S; Patterson S; Zuccotto F; Thompson S; Martin J; Marco M; Miles TJ; De Rycker M; Thomas MG; Fairlamb AH; Gilbert IH; Wyllie S
    ACS Infect Dis; 2020 Mar; 6(3):515-528. PubMed ID: 31967783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the scope of synthetic 1,2,4-trioxanes towards Trypanosoma cruzi and Leishmania donovani.
    Medrán NS; Sayé M; Pereira CA; Tekwani BL; La-Venia A; Labadie GR
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127491. PubMed ID: 32795626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi.
    Oh S; Kim S; Kong S; Yang G; Lee N; Han D; Goo J; Siqueira-Neto JL; Freitas-Junior LH; Song R
    Eur J Med Chem; 2014 Sep; 84():395-403. PubMed ID: 25036797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
    Muscat S; Grasso G; Scapozza L; Danani A
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0010545. PubMed ID: 36689459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
    Croft SL; Snowdon D; Yardley V
    J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease.
    Khare S; Roach SL; Barnes SW; Hoepfner D; Walker JR; Chatterjee AK; Neitz RJ; Arkin MR; McNamara CW; Ballard J; Lai Y; Fu Y; Molteni V; Yeh V; McKerrow JH; Glynne RJ; Supek F
    PLoS Pathog; 2015 Jul; 11(7):e1005058. PubMed ID: 26186534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca
    Gil Z; Martinez-Sotillo N; Pinto-Martinez A; Mejias F; Martinez JC; Galindo I; Oldfield E; Benaim G
    Parasitol Res; 2020 Feb; 119(2):649-657. PubMed ID: 31897791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.
    Bosc D; Mouray E; Cojean S; Franco CH; Loiseau PM; Freitas-Junior LH; Moraes CB; Grellier P; Dubois J
    Eur J Med Chem; 2016 Feb; 109():173-86. PubMed ID: 26774924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Leishmania Hsp90 and Hsp70 are recognized by sera from visceral leishmaniasis patients but not Chagas' disease patients.
    de Andrade CR; Kirchhoff LV; Donelson JE; Otsu K
    J Clin Microbiol; 1992 Feb; 30(2):330-5. PubMed ID: 1537901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil.
    Neal RA; van Bueren J; McCoy NG; Iwobi M
    Trans R Soc Trop Med Hyg; 1989; 83(2):197-8. PubMed ID: 2558433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.
    Roquero I; Cantizani J; Cotillo I; Manzano MP; Kessler A; Martín JJ; McNamara CW
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():58-68. PubMed ID: 31158574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of newly synthesised [1,2,4]triazolo[1,5a]pyrimidine derivatives against Trypanosoma cruzi, Leishmania donovani and Phytomonas staheli.
    Luque F; Fernández-Ramos C; Entrala E; Rosales MJ; Navarro JA; Romero MA; Salas JM; Sánchez-Moreno M
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 May; 126(1):39-44. PubMed ID: 11048663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Methods to Discover Compounds for the Treatment of Chagas Disease.
    Cortés-Ruiz EM; Palomino-Hernández O; Rodríguez-Hernández KD; Espinoza B; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2018; 113():119-142. PubMed ID: 30149904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
    Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R
    J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiparasitic activity and effect of casearins isolated from Casearia sylvestris on Leishmania and Trypanosoma cruzi plasma membrane.
    Bou DD; Tempone AG; Pinto ÉG; Lago JH; Sartorelli P
    Phytomedicine; 2014 Apr; 21(5):676-81. PubMed ID: 24560122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
    Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
    Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives.
    Gómez-Ayala S; Castrillón JA; Palma A; Leal SM; Escobar P; Bahsas A
    Bioorg Med Chem; 2010 Jul; 18(13):4721-39. PubMed ID: 20627590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
    Don R; Ioset JR
    Parasitology; 2014 Jan; 141(1):140-6. PubMed ID: 23985066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitrypanosomal activities of novel pyridylchalcones.
    Bhambra AS; Ruparelia KC; Tan HL; Tasdemir D; Burrell-Saward H; Yardley V; Beresford KJM; Arroo RRJ
    Eur J Med Chem; 2017 Mar; 128():213-218. PubMed ID: 28189085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.
    Magoulas GE; Afroudakis P; Georgikopoulou K; Roussaki M; Borsari C; Fotopoulou T; Santarem N; Barrias E; Tejera Nevado P; Hachenberg J; Bifeld E; Ellinger B; Kuzikov M; Fragiadaki I; Scoulica E; Clos J; Gul S; Costi MP; de Souza W; Prousis KC; Cordeiro da Silva A; Calogeropoulou T
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.